Experts Warn Poor Patient Eligibility Criteria Undermine Clinical Trial Data

A Forbes analysis highlights how poorly designed patient selection criteria and misrepresentation can compromise clinical trial results, offering strategies for sponsors to improve data integrity and trial design.

4 Sept, 13:46 — 4 Sept, 13:46

Post Share

Sources

Showing 1 of 1 sources

forbes1d ago

The Golden Rule Of Patient Eligibility: Defining The Right Population

Poorly designed patient eligibility criteria and patient misrepresentation can undermine clinical trial data. Here’s how sponsors can fix both.

By Gary Zammit, Forbes Books Author

Read full article →

Experts Warn Poor Patient Eligibility Criteria Undermine Clinical Trial Data

Sources

The Golden Rule Of Patient Eligibility: Defining The Right Population

Related Stories

Nigeria Closes Schools in Plateau State Over Diphtheria Outbreak

Singapore Air Quality Improves From Unhealthy to Moderate Levels

West Nile Virus Cases Surpass 1,000 Across Europe

Bangladesh Measles Epidemic Nears 1,000 Child Fatalities